JRJ
FLNA

Jeffrey R. Jay’s Filana Therapeutics FLNA Stock Holding History

Jeffrey R. Jay’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$5.13M Buy
+331,824
New +$7.01M 4.06% 7

Other funds holding FLNA

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MSP
Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Jeffrey R. Jay's FLNA Position: Q2 2013 in Review

Jeffrey R. Jay opened a new position in Filana Therapeutics (FLNA) in Q2 2013: 331,824 shares worth $5.13M. The stake represents 4.06% of the portfolio and ranks #7 among its holdings.

69 funds tracked by Wall St. Rank hold FLNA as of Q2 2013.

  • Jeffrey R. Jay held 331,824 shares of Filana Therapeutics worth $5.13M as of Q2 2013.
  • Filana Therapeutics was a new Jeffrey R. Jay position in Q2 2013.
  • Filana Therapeutics made up 4.06% of Jeffrey R. Jay's portfolio in Q2 2013, its #7 holding.
  • 69 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2013.

Based on Jeffrey R. Jay's 13F filing for Q2 2013, filed 14 Aug 2013.